Reversion analysis reveals the in vivo immunogenicity of a poorly MHC I-binding cancer neoepitope.
Ebrahimi-Nik H, Moussa M, Englander RP, Singhaviranon S, Michaux J, Pak H, Miyadera H, Corwin WL, Keller GLJ, Hagymasi AT, Shcheglova TV, Coukos G, Baker BM, Mandoiu II, Bassani-Sternberg M, Srivastava PK.
Ebrahimi-Nik H, et al. Among authors: mandoiu ii.
Nat Commun. 2021 Nov 5;12(1):6423. doi: 10.1038/s41467-021-26646-5.
Nat Commun. 2021.
PMID: 34741035
Free PMC article.